Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...

The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...

For guest writer Aranzazu Calzado, there's nothing like a wall to remind her that having something to lean on is not about ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

A group of international experts is proposing a first-of-its-kind framework to prevent multiple sclerosis (MS) from ...

Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its ...

Other prenatal exposures -- preterm birth (before 37 weeks gestation), placental abruption, and maternal hypertensive ...

There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

Researchers at McMaster University in Hamilton are observing people with multiple sclerosis as they exercise while they play ...

Elsa Mendoza has been living with the disease for years. Here's more on her battle and what it means to have Multiple Sclerosis.